Compare HCA Health Inc (HCA) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Smith & Nephew plc — how do they compare? HCA Health Inc trades at $410.11 (market cap $89.64B), while Smith & Nephew plc trades at $30.05 (market cap $12.50B). The key difference: HCA Health Inc is far larger — about 7.2× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.64%). Which is the better fit depends on your goals.
| HCA | SNN | |
|---|---|---|
Market Cap | $89.64B | $12.50B |
Sector | Health | Health |
52-Week High | $545.13 | $38.70 |
52-Week Low | $361.32 | $28.73 |
Enterprise Value | $140.18B | $15.53B |
Dividend Yield | 0.75% | 2.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
